SEC Form 4 · accession 0001127602-18-021961
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P. Mr. Burke
Officer — EVP, Chief Financial Officer
Period of report
Jun 25, 2018
Accepted (ET)
Jun 27, 2018 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 25, 2018 | M | 5,717 | $41.64 | A | 21,291 | D | |
| Common StockF2 | Jun 25, 2018 | S | 5,717 | $92.17 | D | 15,574 | D | |
| Common StockF2 | Jun 25, 2018 | S | 970 | $92.17 | D | 14,604 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F3 | $41.64 | Jun 25, 2018 | M | 5,717 | D | Jun 6, 2018 | Jun 6, 2024 | Common Stock | 5,717 | 17,153 | D |
Explanation of responses
- F1Transaction pursuant to an existing 10b5-1 trading plan.
- F2This number includes unvested restricted stock units previously reported.
- F3Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.